FULVESTRANT

17785 reported adverse events

Drug classes: Estrogen Receptor Antagonist [EPC]

These side effects are most commonly reported by patients taking FULVESTRANT:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 2281
1 FATIGUE 2258
2 NAUSEA 1586
3 NEOPLASM PROGRESSION 1387
4 DEATH 1375
5 DIARRHOEA 1242
6 WHITE BLOOD CELL COUNT DECREASED 1221
7 NEUTROPENIA 1204
8 METASTASES TO BONE 1153
9 ASTHENIA 999
See all common reactions for FULVESTRANT

FULVESTRANT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PIK3CA-ACTIVATED MUTATION 88 0.6027
1 INFUSION SITE COLDNESS 23 0.3485
2 CARBOHYDRATE ANTIGEN 27.29 INCREASED 29 0.3085
3 PSEUDOCIRRHOSIS 56 0.2932
4 CARBOHYDRATE ANTIGEN 15-3 INCREASED 112 0.2887
5 PLEURAL NEOPLASM 22 0.1880
6 METASTASES TO EYE 27 0.1875
7 METASTASES TO THORAX 30 0.1695
8 HORMONE RECEPTOR POSITIVE BREAST CANCER 12 0.1690
9 METASTASES TO CHEST WALL 36 0.1607
See all enriched reactions for FULVESTRANT